位置：成果数据库 > 期刊 > 期刊详情页
炎症可能是支架内再狭窄发生的重要机制
  • 期刊名称：中华心血管病杂志
  • 时间：0
  • 页码：210-212
  • 语言：中文
  • 分类：R654.2[医药卫生—临床医学;医药卫生—外科学] R364.5[医药卫生—病理学;医药卫生—基础医学]
  • 作者机构：[1]中国医学科学院北京协和医学院阜外心血管病医院冠心病诊疗中心,100037
  • 相关基金：基金项目：国家自然科学基金资助项目（30670861,30871055）;北京市自然科学基金资助项目（7082081）;教育部高等学校博士学科点项目专项研究基金资助项目（20060023044,20070023047）
  • 相关项目：冠脉慢血流综合征的炎症相关分子机制研究与他汀干预
作者： 李建军|
关键词： 支架内再狭窄, 炎症, 西方国家, 危险因素, 综合治疗, 重建技术, 药物治疗, 冠心病
中文摘要：

冠心病是目前西方国家引起死亡的主要原因，这一状况在将来相当长的时间内仍持续存在。冠心病现代综合治疗主要包括危险因素的控制、药物治疗及血运重建技术。

同期刊论文项目
冠状动脉慢血流现象发生的炎症机制研究
期刊论文 23
冠脉慢血流综合征的炎症相关分子机制研究与他汀干预
期刊论文 34
同项目期刊论文
Gender difference of clinical characteristics in Chinese patients with spontaneous variant angina
炎症与动脉粥样硬化的新视野
Maximizing benefit of drug-eluting stent by direct coronary stenting because of further reduction of
Chronic inflammatory status in patients with coronary artery ectasia
Comparison of Changes in Early Inflammatory Markers Between Sirolimus- and Paclitaxel-Eluting Stent
无痛性心肌缺血与炎症
冠状动脉慢血流综合征与炎症的关系
C反应蛋白:动脉粥样硬化的标志物还是兼具致病作用
内皮祖细胞、动脉硬化与炎症
Atorvastatin Decreases C-Reactive Protein-Induced Inflammatory Response in Pulmonary Artery Smooth M
Is myocardial bridging a bridge connecting to cardiovascular events?
Impact of C-Reactive Protein on In-Stent Restenosis A Meta-Analysis
Treatment of mild-moderate calcified coronary lesions with sirolimus-eluting stent: real world data
Anatomic properties of coronary arteries are correlated to corrected TIMI frame count in coronary sl
C-reactive protein decreases interleukin-8 production in human endothelial progenitor cells by inhib
A multi-center survey of achieving recommended lipid goals in Chinese patients with coronary artery
Increased plasma C-reactive protein level predicts rapid progression of non-target atherosclerotic l
冠状动脉慢血流现象应视为一种新的冠状动脉综合征
炎症机制可能参与心脏X综合征的发生与发展
再狭窄发生的相关研究是冠心病介入治疗的长期课题
支架内再狭窄与炎症相关吗?
Inflammation in coronary artery diseases
冠状动脉慢血流现象的发生机制和临床诊治进展
他汀类药物非调脂作用及其机制（续完）
内皮祖兰田胞、动脉硬化与炎症
炎症与支架内再狭窄
炎症可能是联接高血压和动脉粥样硬化的桥梁
Maximizing benefit of drug-eluting stent by direct coronary stenting because of further reduction of inflammatory response
C-reactive protein decreases interleukin-8 production in human endothelial progenitor cells by inhibition of p38 MAPK pathway
Gender difference of clinical characteristics in Chinese patients with spontaneous variant angina
冠状动脉慢血流综合征与炎症的关系
Is myocardial bridging a bridge connecting to cardiovascular events?
炎症机制可能参与心脏X综合征的发生与发展
再狭窄发生的相关研究是冠心病介入治疗的长期课题
Inflammation in coronary artery diseases
Statin may be beneficial for p
Increased plasma CRP and IL-6
Is there delayed restenosis in
Elevated circulating inflammat
The role of inflammation in co
Is inflammation a contributor
Xuezhikang decrease plasma inf
他汀类药物非调脂作用及其机制（续完）
内皮祖兰田胞、动脉硬化与炎症
炎症与支架内再狭窄
炎症可能是联接高血压和动脉粥样硬化的桥梁
Maximizing benefit of drug-eluting stent by direct coronary stenting because of further reduction of inflammatory response
Inflammatory response, drug-eluting stent and restenosis
C-reactive protein decreases interleukin-8 production in human endothelial progenitor cells by inhibition of p38 MAPK pathway
Angiographic prevalence of myocardial bridging in a defined very large number of Chinese patients with chest pain
Effects of sirolimus-eluting stent on calcified coronary lesions